Enlivex Therapeutics Ltd. sell nvestor
Start price
13.04.24
/
50%
€1.51
Target price
13.04.25
€2.00
Performance (%)
-0.66%
End price
27.04.24
€1.50
Summary
This prediction ended on 27.04.24 with a price of €1.50. The SELL prediction by nvestor for Enlivex Therapeutics Ltd. closed nearly unchanged from the start price. nvestor has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Enlivex Therapeutics Ltd. | 5.512% |
| iShares Core DAX® | 2.594% |
| iShares Nasdaq 100 | 3.553% |
| iShares Nikkei 225® | 0.687% |
| iShares S&P 500 | 2.209% |
According to nvestor what are the pros and cons of Enlivex Therapeutics Ltd. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
negative Cash Flow expected
Few uniques
Growths slower than the competition
Below average Marketposition
Little known brand
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Revenue decline/stagnation expected
Low dividend yield expected
Little Investments for future growth
Risky balance sheet
ROE lower than 10% per year
Bad rating
Increased challenges to pay loans and raise capital
Below average Management
Bad culture
Little innovation
Dependend from some customers or products
Sustainability is little important
high free float
Higher risks for its business
Significant cyclical dependencies
Business model of the past or high risk
Comments by nvestor for this prediction
In the thread Enlivex Therapeutics Ltd. diskutieren
In the thread Trading Enlivex Therapeutics Ltd.
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.